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Abstract
A new type of RNAs was identified from genes traditionally thought to express messenger or linear ncRNA
(noncoding RNA) only. They were subsequently named as circRNAs (circular RNAs) due to the covalently closed
structure. Accumulating studies were performed to explore the expression profile of circRNAs in different cell
types and diseases, the outcomes totally changed our view of ncRNAs, which was thought to be junk by-products in
the process of gene transcription, and enriched our poor understanding of its underlying functions. The expression
profile of circRNAs is tissue-specific and alters across various stages of cell differentiation. The biological function of
circRNAs is multi-faceted, involving five main features (sponge effect, post-transcriptional regulation, rolling circle
translation, circRNA-derived pseudogenes and splicing interference) and varying differently from the locations,
binding sites and acting modes of circRNAs. The regulating role of circRNAs is not isolated but through an
enormous complicated network involving mRNAs, miRNAs and proteins. Although most of the potential
functions still remain unclear, circRNAs have been proved to be ubiquitous and critical in regulating cellular
processes and diseases, especially in cancers, from the laboratory to the clinic. Herein, we review circRNAs’
classification, biogenesis and metabolism, their well-studied and anticipated functions, the current understanding of
the potential implications of circRNAs in tumorigenesis and cancer targeted therapy.
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Background
CircRNA is an up-rising star in ceRNAs (competing en-
dogenous RNAs) field, even in the whole RNA world,
characterized by the distinct structure without termi-
nated 5’ caps and 3’ tails [1]. Although it was previously
discovered as errors in RNA splicing process, its unique
properties and powerful functions are being increasingly
acknowledged by scientists. Natural circRNA has been
proved as an abundant, stable, diverse and conserved
class of RNA molecules which plays an indispensable
role in the RNA interaction network [2]. CircRNA was
found extensive in eukaryotic cells by deep sequencing
technologies, and a large number of researches suggested
that it possesses complicated functions such as competing
with linear RNAs in the splicing, working as endogenous
RNAs to sponge miRNAs, regulating transcription and so
on [3, 4], and it seems that other important but underlying
functions will be revealed as soon as possible. Moreover,
circRNA was confirmed to be associated with varied cellu-
lar process and involve in the biogenesis and development
of many diseases, especially in cancer [5–8], its potential
of serving as diagnostic or predictive biomarkers of dis-
ease has become a hotspot in scientific field up to now. In
this review, we describe the biogenesis, classification,
functions and potential implications in cancer targeted
therapy of circRNA, telling the story of how circRNA
switches from “nobody” to “hero”.
Main text
The discovery and distribution of circRNA: a beautiful
accident with dramatic impact
CircRNAs are a group of non-coding RNAs that are an-
cient yet newly recognized regulating molecules. After
the earliest discover in plant-based virus in 1976 [9],
they just come into scene in recent years and are found
widely spread in eukaryotic cells from flies to mammals
and humans thanks to the technological breakthroughs
in high-throughput deep sequencing [10–12]. But still,
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circRNA was regarded as the functionless junk-RNA de-
veloped from mRNA splicing thus did not get enough
attention as they should be. Until 2013, a famous and
classic paper published by Hansen TB et al. on the jour-
nal of nature has totally changed the fate of circRNA
and turn it into a focal point of scientific research [3].
The subsequent findings indicate that circRNAs have
great potential to perform special regulating roles in bio-
logical development. Thousands of circRNAs were also
suggested to present in plant cells and might act as a
negative regulator of its parental gene through genome-
wide identification and potential function analysis of cir-
cRNAs in rice [13]. Similar with lncRNAs, the expression
profile of circRNAs is specific among different cell types
indicating its possible regulatory function. More and more
studies have suggested that they contribute disease initi-
ation and progression, possess the potential of turning
into new clinical diagnostic and prognostic markers, and
serve new insights into the therapy of cancers.
The formation of circRNA: a slow but ingenious process
Although more and more human circRNAs were identified
and uploaded online using molecular biology strategies
combined with new bioinformatic approaches, the under-
lying mechanisms of circRNA generation are still not clear
yet. There is an assumption that at least four distinct paths
involved in the formation of circRNAs [2, 10, 14, 15].
1. Spliceosome-Dependent Circulation Path.
Most eukaryotic circRNAs are generated during
alternative splicing, an essential step in the
eukaryotic gene expression process that is catalyzed
by either spliceosomal machinery or group I/II
ribozymes [16–18]. The processing of the back-
splicing reaction seems to require the canonical
spliceosome, a kind of cis-regulatory elements
which are able to regulate splicing and catalyse
circulation [12, 19]. Although the detailed mechanism
about how the spliceosome is involved in back-
splicing remains unknown exactly, it is reasonable
to propose that following the sequential assembly
of snRNPs (spliceosomal small nuclear ribonucleo-
proteins) on the pre-mRNA, the downstream 5′
donor site of an exon is combined to an upstream
3′ acceptor site to catalyse circRNA biogenesis.
We already knew that the back-splicing efficiency
is very low compared to the canonical splicing,
this is possibly due to the fact that spliceosomes
are unfavourably assembled at back-splicing.
2. Intron-Pairing-Driven Circularization Path and
Lariat-Driven Circularization Path
Firstly, in the ‘Intron-Pairing-Driven Circularization
Path’ (Fig. 1b), a large number of circRNA are
formed depend on this intronic reverse
complementary motifs, which contain a seven-
nucleotide GU-rich element close to the 5’ splice site
and an 11-nucleotide C-rich element near the
branch point site [15, 20]. The donor-acceptor pairs
on the primitive transcripts can be brought close
enough to promote the circularization of exons
through alternative 5’ to 3’ splicing [14, 21, 22].
Secondly, in the ‘Lariat-Driven Circularization
Path’ (Fig. 1b), the classical skipping process leads
to the generation of the lariat precursor, which
is by-products in exon-skipping event happened
during canonical linear alternative splicing [2],
but represents a key attribute of this model. The
circularization of extros and intros can be promoted
by this specific lariat structure (Fig. 1c). In these two
classical models of circularization, ALU complemen-
tary flanking elements (retrotransposons characterized
by the action of the Arthrobacter luteus (Alu) restric-
tion endonucleas) repeated in intronic regions com-
pete with canonical linear-RNA splicing and act as a
necessary accelerator in the formation of circRNAs by
reverse complementary matches [2, 12, 14]. IRAlu (re-
verse Alu element) has already become an important
basis of analyzing and forecasting the formation
mechanism of circRNA [23].
3. Protein Factors Associated Circulation Path
As in the ‘Intron-Driven Circulation Path’, some
RBPs (RNA binding proteins) can bind to specific
targets in introns and bring the donor-acceptor
sequences in proximity to each other thus trigger
several circularization processes instead of the
intronic reverse complementary motifs. In this
model of circularization, RBPs play a double role
of both stabilizing the splicing motifs and inhibiting
canonical linear splicing in the process of regulating
circRNA generation (Fig. 1c). QKI, one of the well
studied RBPs, involve in the process of human
EMT (epithelial-mesenchymal transition) by regulating
circRNA generation thus play a role in the neoplasm
metastasis. Insertion of QKI binding sites into linear
RNA can induce exon circularization [24]. Besides the
positive functions mentioned above, some RBPs play a
negative role in the process of circRNA formation. For
instance, ADARs (Adenosine deaminases acting on
RNA) were suggested to inhibit circRNA formation
by melting the stem structure [14]. ADARs are highly
conserved proteases binding with double-stranded
RNA, mainly involve in RNA editing, particularly the
process of transforming the adenosine residues in
double-stranded RNA into creatinine [25]. Compared
with the host mRNA, expression level of circRNA was
observed an increase after ADAR knockdown, which
indicating the negative regulating role of ADAR in the
circularization of RNAs [14].
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4. Foramtion rate is actully slow: Long time accumulation
makes the abundance
Previous researches of circRNAs are all reported
in genomics level, since the relatively stable
characteristics of circRNA can achieve its
accumulation within a certain time. The rate of
circRNA formation is still a mystery until now. A
newly published paper showed that the forming
rate of circRNA is actually very low, and the
generation process is related to the rapid extension of
the polymerase II. The researcher took the neurons
as example and drew a final conclusion that circRNA
depends on the cis-elements (reverse complement
sequence inside RNA) in the process of rapid
transcription and the long-time cumulative effect
in cells [26]. We have to admit that the mechanism of
circRNA biogenesis is so complicated and related to
varied regulatory factors. The definitive explanation of
their interaction during the formation of circRNA still
needs further research.
Classification of circRNA: a complicated system
possessing its own special rhythms
Due to the confusion of nomenclatural method in differ-
ent databases and the poor understanding in biogenesis
and characteristics of circRNAs, generating a systematic
circRNAs classification is not an easy task. Up to now,
there are two separate ways to divide circRNAs based on
different principles.
1. Three subsets classification: component-oriented
According to the most existing studies, comprehensive
circRNAs can be classified into three types (Fig. 2),
exonic circRNAs, intronic circRNAs, and exon-intron
circRNAs, focusing on their components [27]. Just as
its name implies, ecircRNAs (exonic circRNAs)
comprise exons generated in the process of exon
skipping in pre-mRNA sequences, and they are
likely to be transported to cytoplasm by the nuclear
export system, or escape from nuclei during cell
division [28]. Cytosolic localization of circRNAs
may also support their post-transcriptional function.
CiRNA (intronic circRNAs) is composed by two or
more connected introns and was detected rare in
eukaryotic cells. EIciRNAs (Exon-intron circRNAs)
are circularized with introns ‘retained’ between the
exons, they could be overexpressed with their flanking
complementary sequences. Both ciRNAs and
eIciRNAs position on transcription sites in nucleus
and have the potential function of promoting the
transcription of their parent mRNAs [29, 30].
2. Five subsets classification: location-oriented
With the development of deep sequencing in varied
species and tissues, some special circRNAs types was
discovered, circRNAs should be classified into five
types, “exonic”, “intronic”, “antisense”, “sense
overlapping” and “intergenic” according to their
location relationship with adjacent coding RNA
(Fig. 3). Except for those two common types
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Fig. 1 Three paths of circRNAs formation. Legend: There are four commonly acknowledged paths in the formation of circRNAs. a Spliceosome-
Dependent Circulation Path: the processing of the back-splicing reaction requires the sequential assembly of snRNPs on the pre-mRNA to catalyse
circulation. b Intron-Pairing-Driven Circularization Path: circRNA are formed depend on an intronic reverse complementary motif containing a GU-rich
element and a C-rich element in two sides to promote circularization. c Lariat-Driven Circularization Path: formation of circRNA is promoted by a lariat
structure; the ALU complementary flanking elements repeated in intronic regions compete with canonical linear-RNA splicing and accelerate
the circularization by reverse complementary matches. d Protein Factors Associated Circulation Path: some RBPs can bind to specific targets in
introns and bring the donor-acceptor sequences in proximity to each other thus trigger several circularization processes. At the mean time,
RBPs also stabilize the splicing motifs and inhibit canonical linear splicing
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composed of intros and extros, “antisense”
represents circRNA whose gene locus overlap with
the linear RNA, but transcribed from the opposite
strand; “sense overlapping” represents circRNA
transcribed from same gene locus as the linear
transcript, but not classified into “exonic” and
“intronic”; “intergenic” represents circRNA located
outside known gene locus. This way of classification
focusing on the location of circRNA in prime
transcripts is more beneficial to research the
interaction between circRNA and their adjacent
coding RNA in some degree.
Fig. 2 Composition of three types circRNAs. Legend: CircRNAs are generated in the process of the skip splicing of pre-mRNA and compete with
the linear transcription, they are generally classified into three types focusing on their components. (1) EcircRNAs comprise exons and are the
most common circRNAs. (2) CiRNAs are composed by two or more connected introns and are detected rare in eukaryocyte. (3) EIciRNAs are
circularized with introns ‘retained’ between the exons and play a part in gene regulation
Fig. 3 The new five subsets classification of circRNAs. Legend: CircRNAs can be divided into five groups according to their location relationship
with coding RNA. “exonic” and “intronic” represent circRNA composed by exons and intros respectively, “antisense” represents circRNA whose
gene locus overlap with the linear RNA, but transcribed from the opposite strand; “sense overlapping” represents circRNA transcribed from same
gene locus as the linear transcript, but not classified into “exonic” and “intronic”; “intergenic” represents circRNA located outside known gene locus
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Useful tools in circRNA research: complementation of
colors makes the whole spring
Large-scale RNAseq has been widely employed for many
purposes in scientific research and substantially changed
the transcriptomics field, especially the circRNAs, as it
enables an unprecedented amount of high resolution
data to be acquired. Except for the established softwares
which are powerful enough to analyze the sequence data,
several current online databases containing circRNAs col-
lected from GenBank annotations or published articles en-
able researchers to organize the circRNAs conveniently.
1. Online-databases of circRNA: different flowers
bloom together
There are many free online databases available for
the circRNA research, each database has its own
characteristics and covers the different part of the
information about circRNAs. For instance, both
starBase v2.0 (http://starbase.sysu.edu.cn/
Accessed 10 Augst 2016) and circBase (http://
www.circbase.org/ Accessed 10 August 2016) allow
the user to search for functional classes or
processes [31, 32]; Two disease-oriented database,
namely circ2Traits (http://gyanxet-beta.com/circdb
Accessed 21 July 2016) and nc2Cancer (http://
www.Bioinfo.Tsinghua.Edu.cn/nc2Cance Accessed 15
July 2016), provide plenty of information about
cirRNA-associated diseases and the genomic posi-
tions of several circRNAs [4, 33]. While CircNet
(http://circnet.mbc.nctu.edu.tw/ Accessed 12 Septem-
ber 2016) and deepBase v2.0 (http://biocenter.sysu.e-
du.cn/deepBase/ Accessed 23 August 2016) contains
the most CircRNA annotation (Annotation of cir-
cRNAs depends on sequencing reads spanning the
backsplice junction and thus map as nonlinear
reads in the genome), especially human CircRNAs
[34, 35]. CircInteractome (http://circinteractome.-
nia.nih.gov Accessed 8
September 2016) will be the only option if you
want to match the circRNA with relevant RNA-
binding proteins [36]. As for the search for sequence
alignment of circRNAs, circBase and CircNet would
be the perfect choice because they are equipped with
a web interface of BLAST. And CircNet is the only
one to provide circRNA expression profiles in
samples. There is no doubt that every database
present with its own sphere of competence, only
the perfect combination of various database can
provide information in a reliable way.
2. A newly established tools with pipeline analysis of
ceRNAs.
Except for the online database, the vast majority of
the existing softwares are very valuable and efficient
in analyzing the raw data from new generation
sequencing, while most of them still pose a challenge
to the researchers without basic programming and
computing skills. Most importantly, the circRNAs
outputs from five different algorithms:
circRNA_finder [37], find_circ [38], CIRCexplorer
[23], CIRI [39], and MapSplice [40], are observed
surprisingly dramatic differences, specifically regarding
the highly expressed circRNAs and the circRNAs
derived from proximal splice sites [41]. In order to
bring together these well-established tools in a single
bundle and achieve reliable predictions, Andrés-León,
E. et al. developed a suite named miARma-Seq [42].
This is a comprehensive pipeline analysis which
can identify mRNAs, miRNAs and circRNAs in
any sequenced organism and enable differential
expression, miRNA-mRNA target prediction or
functional analysis. It runs in three different operative
systems and has been tested for reliance on software
updates, demonstrating the utility of this tool for the
research community [42].
Conservation of circRNAs among species
As a “bridge” between DNA and protein, the complex
regulatory role of RNA has long been underestimated.
In eukaryotic cells, protein-coding RNA (mRNA) only
occupies about 2% of the genome, the rest massive num-
ber of transcripts were classified to non-protein coding
RNAs (ncRNAs). CircRNA was found stable and abun-
dant in cells across species, involving in complex regula-
tory networks of ncRNAs and playing a indispensable
role in the development of non-neoplastic diseases and
tumors [43, 44].
1. Assumption about circRNA/linRNA ratio across tissues
Why would circular RNAs get so much attention?
Recent papers have described the presence of
circular RNA species and their linear counterparts
in different tissues, the outcomes showed that the
ratio of circular to linear RNA isoforms was always
low in colon tumor compared to adjacent normal
colon tissues and even lower in colorectal cancer
cell lines. This phenomenon also presents in ovarian
cancer and its adjacent normal samples [45].
Furthermore, circRNA/linRNA ratio correlates
negatively with the proliferation index of cells. This
negative correlation seems to be a general principle
in human tissues and different kinds of cell lines.
There is a chance that circular and its counterpart
linear RNAs are synthesized by specific splice
activities in a gene (cell type and condition)
dependent ratio. As for proliferating cells, if both
RNA species are evenly distributed to offspring cells
during proliferation, linear RNAs are accurately
controlled by active transcription and degradation
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also leading to newly expressed circRNAs, while
circular RNAs are much more stable and
degradation-resistant. This may be one of the
mechanisms to maintain the constant ratios of
circular to linear isoforms. In contrast, in non-
proliferating cells stable circular RNAs accumulate
whereas linear transcripts are in a regulated steady
state of transcription and degradation. This
accumulating assumption explains perfectly why
the global circRNA abundance of brain is much
higher than other human tissues.
2. Serum exosomes: an efficient circRNA carrier in
human body
Serum exosomes are a kind of membrane vesicles
secreted by maternal cells, containing a bunch of
proteins, mRNAs and miRNAs, possessing varied
functions such as transmitting the biological
information, regulating the behavior of recipient
cell and so on [46, 47]. The latest study found that
there are more than 1000 kinds of circRNAs in
exosomes, wherein the enrichment degree of
circRNAs (exo-circRNA) is even greater than the
mother cell secreting the vesicles, circRNA/linRNA
ratio in exosomes is also 6–10 times of the mother
cell [48]. This conclusion has been extensively
validated in lung, colorectal, breast, stomach, liver
and cervical cancer cell lines [49]. Exo-circRNAs
resist degradation of RNA exonuclease and maitain
stablity after 24 h’ incubation in serum at room
temperature. They can eliminate the inhibition effect
mediated by associated miRNAs in recipient cell.
Thus exo-circRNA has been proved to exist stably in
serum and still retains the original ring like structure
and biological function. Also, its abundence is closely
related to the extent of the tumor load [48].
Powerful functions of circRNA: from the waste to treasure
Just several years ago, circRNA was still considered the
waste of error splice, while up to now, they were proved
gradually to possess better stability, escape the degrad-
ation of RNAase and widely spread in eukaryotic cells
[1, 49, 50]. These deeper understanding of circRNAs’
characteristics paves the way for the reveal of their four
crucial functions (Fig. 4).
1. A super sponge for miRNA
CircRNAs has been identified as a new kind of
ceRNAs that sponge and inhibit relevant miRNAs
by complementary base paring (Fig. 4.1). MiRNA
was believed to bind to the complementary site on
the 3′ UTR (untranslated region) of targeting
mRNAs, inhibiting protein translation or promoting
mRNA degradation on a post-transcriptional level
[51, 52]. MiRNAs are closely related to various ways
of regulation, including body development, virus
defense, hematopoiesis, organ formation, cell
proliferation and apoptosis, fat metabolism, and
so on [53–56]. They have also been reported to
act as potential cancer biomarkers [56].
CircRNAs can affect the biological function of
miRNA, regulating the activity of miRNA-target
gene, thus playing an indirect role in the regulation
on post-transcriptional level. CiRS-7 is a recently
identified human circRNA which harbors more than
70 conventional miR-7 binding sites thus works
as a super-sponge of miR-7 [3, 38]. It was observed
overlapping co-expression with miR-7 in the mouse
brain, particularly in neocortical and hippocampal
neurons. It is resistant to miRNA-mediated target
destabilization, which is normally facilitated by
exonucleolytic decay, thus effectively suppresses
miR-7 activity and results in increased levels of
miR-7-targeted transcripts [38]. Another circular
RNA called SRY, contains many binding sites for
miR-138 and functions as a miR-138 sponge [3, 57].
CirRNAs’ strengthen of miRNA-binding capacity is
much powerful than that of any other ceRNAs [58],
it is why they are always call the “super sponge”.
The self-cleavage of circRNAs can lead to the release
of a large number of inactive miRNA;
2. Post-transcription regulation
Most ciRNA (formed by the introns) position in the
nucleus, almost has no miRNA binding function, yet
what is intriguing is that knocking down ciRNA will
hinder the transcription of the corresponding gene
[21]. Ci-ankrd52 substantially enriches in transcription
initiation region of the relevant gene, and promotes
the function of RNA polymerase II. This study
preliminarily proved that the function of ciRNA
is promoting transcription of corresponding
gene. EIciRNAs (formed by exon and intro) also
predominantly localize in the nucleus and serve as
a regulator for transcriptional control. They were
revealed not only interacting with U1 snRNP but
also enhancing the expression of their parental
genes by specific RNA-RNA interaction between
U1 snRNA and EIciRNAs [29].
CircRNA can work together with RBPs to form a
complex, inhibiting transcription, or directly regulating
the expression of mRNA through Watson-Crick base
pairing rules [38] (Fig. 4.2). Stable circRNAs with
elongated RNA Pol II binding sites have the function
of mediating alternative splicing and transcription by
binding to RNA Polymerase II [21]. Except for QKI,
RBP MBL (muscleblind) is another protein which
has been shown to bind to flanking introns of linear
transcript and trigger the generation of circMbl
(circular muscleblind) [12]. The functional defects
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of MBL is known to cause a serious degenerative
disease called myodystrophy-derived myotonia [59],
which is the most common form of muscular
dystrophy of adulthood characterizing by progressive
muscle atrophy and weakness. On the other hand,
circMbl can strongly compete with canonical splicing
and regulate MBL levels through the highly conserved
MBL-specific binding motifs within the sequence of
circMbl [12]. We can guess that circRNAs may have
a strong association with the understanding and
ultimate treatment of muscle degenerative diseases.
There are also many other circRNAs containing
translation-initiating site possess the similar function
and act as mRNA trap to regulate expression of their
host gene. It hence appears that involving in the
regulation of gene transcription process is another
important functional model of circRNA except for
miRNA Sponge.
3. Rolling Circle Translation
Circular mRNA have been proved to be translated
in eukaryotic cell if it contains a IRES (internal
ribosome entry site) sequence combining directly
with ribosome [60–62]. The eukaryotic ribosomal
40S subunits can initiate the translation both in vitro
and in vivo once they bind to circRNA at the entry
point [63–65]. Furthermore, Naoko Abe, etc. found
that circular RNA containing an ORF (infinite open
reading frame) can also be efficiently translated to
produce proteins in an Escherichia coli cell-free
translation system [62]. There are also other evidences
Fig. 4 Five main functions of circRNA. Legend: CircRNAs possess five main functions which have been validated in some related researches. 1.
MiRNA sponge: circRNAs serve as the platform to bind miRNAs and affect their biological function, regulating the activity of miRNA-target gene.
2. Post-transcription regulation: the stable ciRNA and EIciRNA locate in nucleus, binding to elongating RNA Pol II and promoting transcription. 3.
Rolling Circle Translation: some circRNAs can translate into proteins via a rolling circle amplification mechanism, while only the vitro circRNA till
date has been verified to encode proteins in eukaryotic cells. 4. Generating the circRNA-derived pseudogenes: some circRNAs may be reversely
transcribed to cDNA and integrated into the genome based on an unknown way. 5. Affects alternative splicing: circRNA biogenesis can compete
with pre-mRNA splicing, resulting in lower levels of linear mRNAs and changing the composition of processed mRNA by excluding specific exons
from the pre-mRNA
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showing that circRNA inserted with a GFP (green
fluorescent protein) open reading frame can translate
GFP successfully in E.coli [63, 66]. What’s maybe
more interesting is that some circRNAs can be
translated in living human cells independent of
the participation of the third parts like internal
ribosome entry site, a poly-A tail, or a cap structure,
which is essential for internal initiation in conventional
translation. Moreover, proteins could be synthesised
from these circular RNAs in eukaryotic translation
systems via a manner similar to rolling circle
amplification (RCA) of the polymerase reaction
(Fig. 4.3). Without the need to bind multiple
times with the RNA template, circRNAs can not
only produce a long-repeating peptide sequence,
but also enhance the productivity over a given
period of time compared to its linear counterpart
[62]. These findings told us that translation of
exonic circRNAs present in human cells is more
probable than previously thought. However, only
the vitro circRNA is known to encode proteins in
eukaryotic cells, there is no direct evidence till
date to prove that natural eukaryotic endogenous
circRNAs can be translated.
4. Generating the circRNA-derived pseudogenes
Given the unique structure, highly conservative
sequence, absolute stability and rich content of
circRNAs, is there any chance that stable circRNA
molecules could possibly be reversely transcribed
and integrated into the genome, forming the
RNA-derived pseudogenes? Researchers analyzed
the corresponding circularization sites (exon 6-
exon 2) of circRFWD2 in mouse genome, found
33 “highly credible circRFWD2-derived pseudogene”,
9 “lowly credible circRFWD2-derived pseudogenes “,
and six pseudogene containing exon sequences
located outside of circRFWD2. LINE-1 mediated
RNA reverse transcription usually require the
existence of Poly (A), yet 39 of 42 circRFWD2
related pseudogenes contain no Poly (A) sequence,
This illustrates that some circRFWD2 may be
reversely transcribed to cDNA and integrated into
the genome based on an unknown way (Fig. 4.4).
In addition circRFWD2, there are other cases of
circRNA-derived pseudogene, such as circSATB1-
derived pseudogenes presenting in the genome of
all known mouse strains and circDIAP3-derived
pseudogenes only presenting in parts of the strains.
The circPRKDC and circCAMSAP1-derived
pseudogenes found in human genome also
present in gorillas and chimpanzees, but do
not exist in rhesus monkeys. Interestingly, the
circSATB1-derived pseudogene discovered in
mouse MEL and G1E cell lines contains CTCF
binding sites, which are missing in exon region
of corresponding SATB1 gene. The human genome
shows no a similar situation.
This strange phenomenon reminds us that we
should be careful about the interference of circRNA-
derived pseudogenes on the experimental results
during the study circRNA. Although the total
quantity is low up to now, the finding of
circRNA-derived pseudogenes hints a previously
regardless impact of circRNAs on host genome
by retrotransposition.
5. Cyclization process affects alternative splicing
CircRNA is generally accepted as a unique
functional by-products derived from splicing process
of protein-coding genes. A large proportion of
circRNAs we identified till date are exon-derived.
Thus, the forming process of such circRNAs
could affect alternative splicing of the relevant
pre-mRNAs, potentially leading to altered gene
expression (Fig. 4.5). A paper published in Circulation
Research pointed that RBM20 is crucial for the
formation of a subset of circRNAs that originate
from the I-band of the Titin gene. In RBM20-
knockout mice, exons that originally corresponded
to the formation of circular RNA were found more
concentrated in linear RNA [67]. The authors
speculate that these exons may be part of the
precursor RNA transcribed by Titin gene, they
are cleaved from precursor RNA molecule and
further forms circRNAs with the aid of RBM20
in a normal situation. When RBM20 is mutated
or knocked out, these exon sequences cannot be
normally cut down to start the cyclization, and
finally accumulate in the linear RNA molecules.
On the contrary, circRNA biogenesis can compete
with pre-mRNA splicing, resulting in lower levels of
linear mRNAs and changing the composition of
processed mRNA by excluding specific exons from
the pre-mRNA. Although no natural eukaryotic
endogenous circRNA is yet proved to possess the
function of translating into proteins, considering
the principle we mention above that the more
exons are circularized, the less they will be
present in the processed mRNA, it is reasonable
to speculate that the overexpression or deletion of
some gene splicing associated proteins may also
modulate formation of mRNA by affecting the amount
of circRNAs, further regulate gene expression. This
theory will offer a brand-new perspective for the
nosogenesis research of some disease.
In consideration of the numerous unsolved
problems about circRNAs as yet, more reliable
researches are needed to discover the potential
existence of other unknown circRNAs or functional
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RNAs, and complete their functional
characterization in eukaryotic cells.
Conclusion
CircRNA in CNS: a burgeoning aging milestone
The enormous abundance of circRNAs in brain com-
pared to other normal or cancerous human tissues an-
nounces their preferred derivation from neural genes
and intensive accumulation in neural tissues [68]. But
this dose not cover the whole story, circRNAS was re-
vealed increasing substantially relative to their linear iso-
forms during CNS aging. This age-related accumulation
of circular RNA might have implications for its potential
of working as a promising aging marker [37]. Besides the
apparent aging indicators like skin winkles and gray hair,
circRNA might be able to tip the aging of brain and in-
ternal organs in advance, alarming human to take some
preventive measures before it is too late. In addition,
many brain circRNAs changed their abundance abruptly
at a time corresponding to synaptogenesis, they also ex-
hibit a substantial up- or downregulation when the
homeostasis of neuronal activity changes [19]. Brain cir-
cRNAs are suggested to regulate synaptic function and
go hand in hand with the development of nervous sys-
tem, this important discovery adds further dimension to
our understanding of the molecular pervasiveness and
importance of circular RNAs.
CircRNAs in non-neoplastic diseases: a double-edged
sword
CiRS-7 was firstly found in large amounts in human
brain tissue and was also termed CDR1 (cerebellum
degeneration-related antigen 1, CDR1,also known as
CDR34) because of its transcription in the antisense
orientation with respect to the CDR1 gene, which has
been implicated to be crucial in autoimmune neurologic
disorders like Alzheimer’s disease [69–71]. CircRNA
CANRIL was identified to be relevant to the risk of hu-
man atherosclerosis [2]. Also, the over-expressed HRCR
(heart-related circRNA) attenuates the development of
cardiac hypertrophy and heart failure in mice by directly
binding to miR-223 and acting as an endogenous
super sponge to inhibit miR-223 activity, which re-
sults in the increasing expression of ARC, a target for
miR-223, in heart cells [6].
Some circRNAs are even able to possess the function
of regulating cell cycle progression. Circ-Foxo3 is a
highly expressed circular RNA in non-cancer cells, silen-
cing endogenous circ-Foxo3 accelerates cell proliferation
while ectopic expression of circFoxo3 hampers cell cycle
progression [72]. Circ-Foxo3 was shown to bind with
the cell cycle proteins CDK2 and p21 to form a ternary
complex. Normally, CDK2 (cyclin-dependent kinase 2) is
a well-known cell cycle facilitator interacting with
cyclinA and cyclinE [73], while p21 (cyclin-dependent
kinase inhibitor 1) restrains these activities and arrest
cell cycle progression [74]. The formation of circ-Foxo3-
p21-CDK2 ternary complex blocks cell cycle progression
by arresting the function of CDK2 [72]. May be the dys-
regulation of circ-Foxo3 is relevant to the neuromuscular
degenerative diseases or even the germination of cancer.
CircRNAs in cancer: a promising biomarker
Some researchers provide evidences that circ_001569 acts
mechanically as a miRNA sponge to inhibit miR-145 ac-
tivity, and subsequently up-regulates miR-145 targets
E2F5, BAG4 and FMNL2 to promote cell proliferation
and invasion in CRC (colorectal cancer) [7]. Cir-ITCH
was also shown to inhibit the development and progres-
sion of CRC and ESCC (esophageal squamous cell carcin-
oma) [75, 76]. Nowadays, a larger number of circRNAs
was found to significantly express differentially between
ovarian epithelial carcinoma and normal adjacent tissue
than mRNA. Furthermore, the expression profile of cir-
cRNA in primary ovarian epithelial carcinoma and meta-
static carcinoma is also different [8]. Hsa_circ_002059 has
been proved to be down-expressed in gastric tumor sam-
ples compared to the normal gastric mucosa and may be
used as a potential biomarker in the early diagnosis of
gastric cancer [77]. The hsa_circRNA_104912 level was
significantly lower in LSCC (laryngeal squamous cell car-
cinoma) than in corresponding adjacent non-neoplastic
tissues, playing an important role in the tumorigenesis of
LSCC [78]. We can assume that perhaps the different ex-
pression of circRNA is associated with tumor metastasis
and invasion. In brief, circRNAs are gradually found to
play a potential and necessary role in the biogenesis of all
kinds of tumors. Further, circRNAs present a more robust
expression pattern across patients than their linear coun-
terparts indicating their suitability as biomarkers in highly
heterogeneous cancer transcriptomes for diagnostic and
therapeutic implications.
F-circRNA: a new sight in hematologic malignancies
Chromosomal translocations give rise to oncogenic fu-
sion gene thus encode fusion proteins which have been
shown to contribute to tumorigenesis [79, 80]. PML/
RARa and BCR-ABL are the most famous and recurrent
fusion gene in patients with APL (acute promyelocytic
leukemia) and CML (chronic granulocytic leukemia) re-
spectively [81]. These two well-established fusion gene
has become the effective therapeutic targets and reliable
prognosis assessment indicators. Then whether such gen-
omic alterations also affect noncoding RNAs, particularly
circRNAs? Jlenia Guarnerio found that cancer-associated
chromosomal translocations did give rise to f-circRNA
(fusion circRNAs), these newly recognized cirRNAs can
be generated by transcribed exons of distinct genes in
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translocation process [82]. Patients carrying the PML/
RARa or MLL/AF9 translocation (confirmed by the use of
convergent primers spanning the break point) was con-
firmed to display the expression of several f-circRNAs
composed by different exons. Furthermore, the formation
of f-circRNAs is not an exclusive feature of leukemic cells,
it is also universal in tumors of different histological ori-
gins. The EWSR1/FLI1 [83] and EML4/ALK1 [84] trans-
location common in solid tumors such as Ewing Sarcoma
and lung cancer, could also generate associated f-
circRNAs. F-circRNAs promote cellular transformation,
contribute cell survival upon therapy and confer resistance
to treatment in tumor cells. But f-circM9 (fusion circRNA
MLL/AF9) was proved probably not sufficient to trigger
tumorigenesis on its own, it plays an active role in favoring
leukemia progression in vivo when coupled with other
oncogenic stimuli (e.g., the presence of the oncogenic fu-
sion protein) [82]. This paper expands our current know-
ledge concerning molecular mechanisms of cancer onset
and progression, indicating potential diagnostic and thera-
peutic implications.
CircRNAs involve in signaling pathways: a potential target
for treatment
There is research shows that circular and linear expres-
sion exhibits an inverse trend in many cancer related
pathways. Signaling pathways like NF-kB, ILK and TGF-
β, which are essential for epithelial to mesenchymal
transition and typically over expressed for mRNA in
metastatic tumors, are suggested down regulated for cir-
cRNA [8]. Similarly, proliferative signaling pathways
(PI3k/AKT, JAK/STAT), angiogenesis pathways (VEGF,
ILK) and HGF signaling were activated for linear mRNA
transcripts and down regulated for circular RNA in me-
tastases. Conversely, PTEN and PPAR signaling path-
ways, whose inactivation leads to carcinogenesis, were
observed a downregulation in mRNA transcripts yet a
corresponding upregulation of circRNA in metastases
[8]. As we know, ITCH is an anti-cancer protein targeting
p63, p73, and Notch1 gene and usually involve in tumor
formation and chemosensitivity [85]. Cir-ITCH was shown
to play an inhibitory role in the development and progres-
sion of colorectal cancer and esophageal squamous cell
carcinoma and it may interact with the miRNAs (miR-7,
miR-17, miR-214) thus increasing the level of ITCH, which
works as inhibitor of Wnt /β-catenin signaling pathway,
exerting an anti-neoplastic effect [75, 76].
Unsolved problems in circRNA: golden mine waiting to be
tapped
Majority of current studies all lend a strong support for
the notion that circRNAs play fundamental roles in vari-
ous disease, especially tumors. However, the function of
large amounts of circRNAs which have been detected
inside animal cells still remains largely unknown and
awaits further detailed study. Thankfully, the results of
existing researches have several interesting implications
concerning circRNAs biology and toward disclosing the
authentic involvement of circRNAs in various disease
and cellular process.
As already stated in our previous section, the expres-
sion levels of circRNA was observed an increase after
ADAR knockdown compared with the host mRNA. This
finding is actually very interesting. You can imagine that
if the level of ADAR decreases transiently in physio-
logical state, it is perhaps the perfect time when cir-
cRNAs start to play a role. Prior studies have shown that
stem cells can differentiate into neurons if ADAR gene
expression in embryonic stem cells is reduced. Then,
whether circRNA is involved in stem cell differentiation?
What role dose circRNA plays in abnormal differentiation
of hematopoietic stem cell associated hematological ma-
lignancy? Whether the high stability of circRNA has a re-
lationship with the memory retention of human brain and
the memory-mediated killing effect of T-lymphocytes?
Maybe circRNA can help us fully understand and effect-
ively treat the brain degenerative diseases and haemato-
logical malignancies.
We all know that circRNAs highly exist in permanent
cells (neuron and cardiomyocyte) and accumulate as
time goes on, then how to explain this phenomenon? Is
the process of aging gives enough time for circRNAs to
gather or the accumulation effect of circRNA promotes
the occurrence of aging? What about the target miR-
NAs? Do they still bind with circRNAs sponge and in-
crease synchronously during the aging process? What
will happen to miRNAs after their release in a inactive
state from the cleaved circRNAs? What contributes do
the interaction between circRNA, miRNA and their par-
ental gene serves in the process of aging and functional
organ degeneration? These questions are all worthy of
further study. Maybe 1 day human can unveil the mys-
tery of aging by researching these promising RNAs.
As a footnote to distinguish varied circRNAs, the naming
of circRNAs today is still based on the RNA sequencing
tools, which differs significantly from each other. This
chaos existing in naming method causes the difficulty of
circRNA classification. A normative and widely accepted
naming system is necessary. With the gradual understand-
ing of circRNA’s biogenesis and functions, there is a hope
that majority of the circRNAs can be named according to
the well-studied miRNA they bind or the star gene
they regulate. The most famous example is ciRS-7 and
CDR1as. Considering the many-to-one relationship be-
tween miRNA, cirRNA and their mother-gene, an internal
numbering system is required. With this complete naming
system, we can assume a circRNA’s source and potential
function after the first sight of its name, isn’t great?
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